Compare HWKN & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HWKN | HAE |
|---|---|---|
| Founded | 1938 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 1995 | 1996 |
| Metric | HWKN | HAE |
|---|---|---|
| Price | $141.93 | $58.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $200.00 | $85.38 |
| AVG Volume (30 Days) | 117.4K | ★ 619.6K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.57% | N/A |
| EPS Growth | 12.26 | ★ 44.54 |
| EPS | ★ 3.17 | 2.46 |
| Revenue | ★ $974,431,000.00 | $910,373,000.00 |
| Revenue This Year | $12.37 | N/A |
| Revenue Next Year | $6.30 | $5.31 |
| P/E Ratio | $41.65 | ★ $23.79 |
| Revenue Growth | ★ 6.01 | N/A |
| 52 Week Low | $102.00 | $47.32 |
| 52 Week High | $186.15 | $87.32 |
| Indicator | HWKN | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 34.23 |
| Support Level | $120.35 | $48.47 |
| Resistance Level | $155.66 | $66.86 |
| Average True Range (ATR) | 6.41 | 1.53 |
| MACD | -1.25 | -0.14 |
| Stochastic Oscillator | 47.66 | 10.70 |
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.